NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug trial halted early, but data may guide future treatments
Disease control TerminatedThis early-phase study tested a drug called EO-3021 in 88 adults with advanced stomach or other solid tumors that have a specific marker (CLDN18.2). The goal was to check safety and see if tumors shrink. The study was stopped early, but the results help researchers understand how…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1 • Sponsor: Elevation Oncology • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Targeted therapy shows promise in rare lung cancer trial, but study ends early
Disease control TerminatedThis study tested a targeted pill called pralsetinib against standard chemotherapy in people with a rare type of advanced lung cancer driven by a RET gene fusion. The goal was to see if pralsetinib could delay cancer growth better than chemo. The trial was stopped early, but resu…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New drug cocktail for advanced kidney cancer shows early promise, but trial halted
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medications (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial wa…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC